Literature DB >> 10565623

Quality of life in patients with upper gastrointestinal symptoms: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST).

P Enck1, D Dubois, P Marquis.   

Abstract

BACKGROUND: Our purpose was to evaluate the impact of upper gastrointestinal (GI) symptoms on quality of life (QoL), which was assessed using the Psychological General Well-Being Index (PGWBI) and the three-item Interference with Daily Life Index (IDLI).
METHODS: The Domestic/International Gastroenterology Surveillance Study (DIGEST) was conducted among 5581 respondents (mean age 44 years) from 10 countries (seven European countries plus Canada, USA and Japan).
RESULTS: Approximately 25% of the respondents reported conditions such as hypertension, asthma or diabetes, and a mean of 46.4% reported at least one GI symptom. The most frequent symptoms were heartburn, diarrhoea and postprandial fullness. Approximately 10-20% of the respondents reporting individual symptoms experienced these several times a week. Symptoms were considered as severe or interfering 'quite a lot' with daily activities by at least 7.3% and 4.8% of respondents, respectively. PGWBI scores varied from 71.82 (Italy) to 79.43 (Switzerland) and daily activity scores from 88.62 (USA) to 97.78 (Switzerland). Female gender, medical conditions and presence of GI symptoms were associated with significantly impaired wellbeing and daily life. PGWBI and IDLI scores were lower among respondents with relevant upper GI symptoms than non-upper GI symptoms. Among upper GI symptom groups, subjects with ulcer-like symptoms had lower scores than patients with GERD-like or dysmotility-like symptoms. PGWBI and IDLI scores were found to discriminate between respondents reporting different symptom frequencies and severities.
CONCLUSIONS: Results from the DIGEST demonstrate on a large scale the importance of GI symptoms in daily life and their influence on QoL.

Entities:  

Mesh:

Year:  1999        PMID: 10565623     DOI: 10.1080/003655299750025264

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  29 in total

1.  A 9 year prospective cohort study of endoscoped patients with upper gastrointestinal symptoms.

Authors:  Johanna I Westbrook; Anne E Duggan; John M Duggan; Mary T Westbrook
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 2.  The impact of gastroesophageal reflux disease on quality of life.

Authors:  T Kamolz; R Pointner; V Velanovich
Journal:  Surg Endosc       Date:  2003-06-13       Impact factor: 4.584

3.  Quality of life in GERD and Barrett's esophagus is related to gender and manifestation of disease.

Authors:  Quinn K Lippmann; Seth D Crockett; Evan S Dellon; Nicholas J Shaheen
Journal:  Am J Gastroenterol       Date:  2009-09-15       Impact factor: 10.864

4.  Evaluation of health-related quality of life using EQ-5D in Takamatsu, Japan.

Authors:  Ai Fujikawa; Takeshi Suzue; Fumihiko Jitsunari; Tomohiro Hirao
Journal:  Environ Health Prev Med       Date:  2010-07-07       Impact factor: 3.674

5.  The effects of proton pump inhibition on patient-reported severity of dyspepsia when receiving dual anti-platelet therapy with clopidogrel and low-dose aspirin: analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial.

Authors:  M Vardi; B L Cryer; M Cohen; A Lanas; T J Schnitzer; P Lapuerta; M A Goldsmith; L Laine; G Doros; Y Liu; A I McIntosh; C P Cannon; D L Bhatt
Journal:  Aliment Pharmacol Ther       Date:  2015-05-29       Impact factor: 8.171

6.  Heartburn in patients with gastro-oesophageal reflux disease in Germany and Sweden: a study on patients' burden of disease.

Authors:  Roger Jones; Silke Horbach; Peter Sander; Tina Rydén-Bergsten
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

7.  Gastric Electrical Stimulation and Sacral Electrical Stimulation: A Long-Term Follow-Up Study of Dual-Device Treatment.

Authors:  Anubhav Agrawal; Sean Lamar Francis; Nicolette Elizabeth Deveneau; Shaily Jain; Christopher Abrasley; Jason Trippe McNeese; Shivangi T Kothari; Christopher J Lahr; Thomas L Abell
Journal:  Dig Dis Sci       Date:  2015-08-18       Impact factor: 3.199

8.  Validation of Self-administrated Questionnaire for Psychiatric Disorders in Patients with Functional Dyspepsia.

Authors:  Ada W Y Tse; Larry H Lai; C C Lee; Kelvin K F Tsoi; Vincent W S Wong; Yawen Chan; Joseph J Y Sung; Francis K L Chan; Justin C Y Wu
Journal:  J Neurogastroenterol Motil       Date:  2010-01-31       Impact factor: 4.924

9.  Obesity as a risk factor for GERD in Japan.

Authors:  Masahiro Sakaguchi; Hiroshi Oka; Takashi Hashimoto; Yutaka Asakuma; Miyuki Takao; Goki Gon; Makoto Yamamoto; Yoshihisa Tsuji; Norihiko Yamamoto; Mamoru Shimada; Kyowon Lee; Kiyoshi Ashida
Journal:  J Gastroenterol       Date:  2008-02-24       Impact factor: 7.527

10.  Impact of PPIs on patient focused symptomatology in GERD.

Authors:  Abr Thomson
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.